US FDA News: FDA warns against the use of homeopathic teething tablets and gels

The U.S. Food and Drug Administration is warning consumers that homeopathic teething tablets and gels may pose a risk to infants and children. The FDA recommends that consumers stop using these products and dispose of any in their possession.
Read more: FDA warns against the use of homeopathic teething tablets and gels

US FDA News: Homeopathic Teething Tablets and Gels: FDA Warning - Risk to Infants and Children

Adverse events reported to the agency, including seizures in infants and children who were given these products.
Read more: Homeopathic Teething Tablets and Gels: FDA Warning - Risk to Infants and Children

Pharma Reviews: Pharma Regulatory Expert Dirk Rodgers To Speak At UNIQUITY India Conference

The United States is the largest market for healthcare products in the world, and India is one of the largest sources of drugs and active pharmaceutical ...
Read more: Pharma Regulatory Expert Dirk Rodgers To Speak At UNIQUITY India Conference

Pharma Reviews: Drug Firms Facing Challenging Times Due To Price Control: Cipla

New Delhi: Drug companies are facing a tough environment due to the ... Now that our Indian pharma industry is at the forefront of healthcare, the ...
Read more: Drug Firms Facing Challenging Times Due To Price Control: Cipla

Pharma Reviews: Sun Pharma To Shut Some Plants In India, Overseas

India's largest drug maker Sun Pharmaceutical Industries Ltd will shut down some of its manufacturing plants in India as well as overseas as the ...
Read more: Sun Pharma To Shut Some Plants In India, Overseas

US FDA News: FDA Statement from Todd Simpson, FDA Chief Information Officer (CIO) on GAO Report Regarding FDA’s IT Security Program

Information security and the protection of industry and public health information are among the FDA’s highest priorities and we do not take lightly the recommendations provided by the GAO in its June 2016 report.
Read more: FDA Statement from Todd Simpson, FDA Chief Information Officer (CIO) on GAO Report Regarding FDA’s IT Security Program

Pharma Reviews: Top jobs that Indians prefer and why

They are called medical representatives and are hired by pharmaceutical companies to market their products. According to Indian regulations, most ...
Read more: Top jobs that Indians prefer and why

Pharma Reviews: Drug firms facing challenging times due to price control: Cipla

Many countries are dependent on India for their drugs. Now that our Indian pharma industry is at the forefront of healthcare, the government should be ...
Read more: Drug firms facing challenging times due to price control: Cipla

Pharma Reviews: Drug firms facing challenging times due to price control: Cipla

Drug companies are facing a tough environment due to the government ... Now that our Indian pharma industry is at the forefront of healthcare, the ...
Read more: Drug firms facing challenging times due to price control: Cipla

Pharma Reviews: Replacement hiring to overtake growth hiring in pharma industry in India: TeamLease Services

Indian pharmaceutical industry continues to show robust growth in hiring compared to other industries in the country. There has been a growth in ...
Read more: Replacement hiring to overtake growth hiring in pharma industry in India: TeamLease Services

Pharma Reviews: Pharma veterans spot an opportunity in FDA Mess

The firm has pulled senior representatives from top drug companies and aims to become the Indian version of large pharma consultancy firms such as ...
Read more: Pharma veterans spot an opportunity in FDA Mess

US FDA News: Small Battery Drive and Small Battery Drive II Adaptor and Light Adaptor by DePuy Synthes: Class I Recall - Possible Explosion Risk

Potential for the adaptors to produce extreme internal pressure, which may cause the device to explode. The use of affected products may cause serious adverse health consequences, including death.
Read more: Small Battery Drive and Small Battery Drive II Adaptor and Light Adaptor by DePuy Synthes: Class I Recall - Possible Explosion Risk

US FDA News: FDA approves first automated insulin delivery device for type 1 diabetes

The U.S. Food and Drug Administration today approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.
Read more: FDA approves first automated insulin delivery device for type 1 diabetes

Pharma Reviews: India making a mark in pharmaceutical industry, says Union Health Minister J P Nadda

India making a mark in pharmaceutical industry, says Union Health Minister J P Nadda. The Health Minister said that his ministry is trying to strengthen ...
Read more: India making a mark in pharmaceutical industry, says Union Health Minister J P Nadda

Pharma Reviews: #dna Edit: Judicious succour to regulate drug pricing

The Indian Pharmaceutical Alliance (IPA), a group of pharma companies, had gone to court against the notification pointing out that these drugs did ...
Read more: #dna Edit: Judicious succour to regulate drug pricing

Pharma Reviews: Cipla aims to reach $1bn India sales through tie-ups

MUMBAI: Cipla, ranked third in the $17-billion Indian pharmaceutical market after Sun Pharma and Abbott, is setting its eyes on reaching a billion ...
Read more: Cipla aims to reach $1bn India sales through tie-ups

Pharma Reviews: Pharmexcil honours Ajanta Pharma Ltd

Speaking on the occasion, Purushottam said, “The Indian Pharma industry's exports are growing by leaps and bounds and in the coming years, it may ...
Read more: Pharmexcil honours Ajanta Pharma Ltd

Pharma Reviews: Pharmaceuticals: Here's why Alkem, Alembic are set to gain

Secular growth in domestic India pharma market (IPM) to continue, despite short-term regulatory issues. Companies with emerging focus on chronic ...
Read more: Pharmaceuticals: Here's why Alkem, Alembic are set to gain

Pharma Reviews: Medicines galore but few doctors

On the contrary, India's pharmaceuticals industry is booming. The industry's drug exports, too, are booming despite occasional raids and bans by the ...
Read more: Medicines galore but few doctors

Pharma Reviews: Suven Life Sciences gets two product patents in India and Japan

suven Drug manufacturer Suven Life Sciences Ltd said it got two product patents in India and Japan for to a new compound for the treatment of ...
Read more: Suven Life Sciences gets two product patents in India and Japan

Pharma Reviews: Indian Drug Formulation Market Grows 15.3% In Aug

Indian companies grew by 17.1% against 9% growth for MNC pharma ... In revenue terms, Indian companies degrew by 11.1% in the FDC portfolio ...
Read more: Indian Drug Formulation Market Grows 15.3% In Aug

Pharma Reviews: Delisting and regulator's inaction failed to improve market capitalization of pharma entities

Though the overall financial performance of Indian pharmaceutical companies improved during last five years, few majors lost ground heavily and put ...
Read more: Delisting and regulator's inaction failed to improve market capitalization of pharma entities

Pharma Reviews: Indian drug formulation market grows 15.3 pc in Aug

Mumbai, Sep 25: The domestic formulation drug market grew by 15.3 per cent in August to Rs 9,643 crore over the corresponding month last year.
Read more: Indian drug formulation market grows 15.3 pc in Aug

Pharma Reviews: Indian drug formulation market grows 15.3 pc in August

Indian drug formulation market grows 15.3 pc in August. Indian companies grew by 17.1 per cent against 9 per cent growth for MNC pharma ...
Read more: Indian drug formulation market grows 15.3 pc in August

Pharma Reviews: Indian drug formulation market grows 15.3% in Aug

The domestic formulation drug market grew by 15.3% in August to Rs 9,643 ... Indian companies grew by 17.1% against 9% growth for MNC pharma ...
Read more: Indian drug formulation market grows 15.3% in Aug

Pharma Reviews: Indian drug formulation market grows 15.3% in August

Indian drug formulation market grows 15.3% in August. The domestic formulation drug market grew by 15.3 percent in August to Rs 9,643 crore over ...
Read more: Indian drug formulation market grows 15.3% in August

Pharma Reviews: Indian drug formulation market grows 15.3 pc in Aug

Mumbai, Sep 25 (PTI) The domestic formulation drug market grew by 15.3 per cent in August to Rs 9,643 crore over the corresponding month last year ...
Read more: Indian drug formulation market grows 15.3 pc in Aug

US FDA News: FDA approves expanded indications for Ilaris for three rare diseases

The U.S. Food and Drug Administration today approved three new indications for Ilaris (canakinumab). The new indications are for rare and serious auto-inflammatory diseases in adult and pediatric patients:
Read more: FDA approves expanded indications for Ilaris for three rare diseases

US FDA News: FDA approves Amjevita, a biosimilar to Humira

The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases.
Read more: FDA approves Amjevita, a biosimilar to Humira

Pharma Reviews: Oil-for-drugs: no clarity yet on barter with Venezuela

As of now, Venezuela, Nigeria and Angola have turned 'problematic' in repatriations for Indian pharma companies. As per industry estimates, over ...
Read more: Oil-for-drugs: no clarity yet on barter with Venezuela

Pharma Reviews: Proposal to Venezuela to settle dues via oil awaiting reply

Indian pharmaceutical exporters are facing issues in getting payments from Venezuela due to the government's regulation on repatriation. The South ...
Read more: Proposal to Venezuela to settle dues via oil awaiting reply

Pharma Reviews: Pharmaceutical Newsletter - September 19 to 23, 2016

This week saw Lincoln Pharma develop new NDDS formulation in India, Aurobindo Pharma gets tentative approval of Dolutegravir 50mg from USFDA.
Read more: Pharmaceutical Newsletter - September 19 to 23, 2016

Pharma Reviews: Pharmexcil organises Pharma CEOs Conclave 2016 as part of its 12th annual meet

The Pharmaceutical Export Promotion Council of India (Pharmexcil) in association with ministry of commerce, government of India, has organised the ...
Read more: Pharmexcil organises Pharma CEOs Conclave 2016 as part of its 12th annual meet

Pharma Reviews: e-health & UCPMP deter pharma cos from unethical marketing practices: Phanish Chandra

Talking about barriers in implementation of UCPMP in the country, he said Indian pharma sector is highly competitive and dominated by the generics.
Read more: e-health & UCPMP deter pharma cos from unethical marketing practices: Phanish Chandra

Pharma Reviews: Pharma companies benefit, infrastructure lose out due to Ind AS

MUMBAI: As India Inc adapted the new accounting standards, Ind AS, there was a jump in net income of pharma companies and increased losses of ...
Read more: Pharma companies benefit, infrastructure lose out due to Ind AS

Pharma Reviews: India, EU to ink pact on pharma exports soon

India had deferred FTA talks with EU in August last year as it was ... Indian pharmaceutical companies are still keeping fingers crossed as they are yet ...
Read more: India, EU to ink pact on pharma exports soon

Pharma Reviews: India seeks barter in Venezuela

Several Indian pharma companies have taken a hit due to curbs imposed by the Venezuelan government on the transfer of foreign currency.
Read more: India seeks barter in Venezuela

US FDA News: Sterile Products by Wells Pharmacy Network: Recall - Concern for Lack of Sterility Assurance

Administration of a drug product intended to be sterile that has microbial contamination may result in infections that may be serious and life-threatening.
Read more: Sterile Products by Wells Pharmacy Network: Recall - Concern for Lack of Sterility Assurance

Pharma Reviews: Pharmexcil organises Pharma CEOs Conclave 2016

Indian Pharmaceutical Industry has come to be recognised as "Pharmacy of the World" with the presence in all the therapeutic segments with almost ...
Read more: Pharmexcil organises Pharma CEOs Conclave 2016

Pharma Reviews: Mukesh Ambani tops Forbes' 100 Richest Indians list; Sun Pharma's Dilip Shanghvi bags no 2 spot

Reliance Industries Chairman Mukesh Ambani has grabbed the top most position in the Forbes' '100 Richest Indians' list with a net worth of $22.7 ...
Read more: Mukesh Ambani tops Forbes' 100 Richest Indians list; Sun Pharma's Dilip Shanghvi bags no 2 spot

Pharma Reviews: Stay Focused on Your Goals

Back then, Lupin was largely an India focused company but I was ... The recent acquisition of Gavis (the largest by an Indian pharma company in the ...
Read more: Stay Focused on Your Goals

Pharma Reviews: Proposal to Venezuela to settle dues via oil awaiting reply

Press Trust of India | Hyderabad September 22, 2016 Last Updated at ... A Pharmexcil office-bearer said Indian pharma companies are to get about Rs ...
Read more: Proposal to Venezuela to settle dues via oil awaiting reply

Pharma Reviews: Mukesh Ambani tops Forbes' 100 Richest Indians list; Sun Pharma's Dilip Shanghvi bags no 2 spot

Mukesh Ambani tops Forbes' 100 Richest Indians list; Sun Pharma's Dilip ... As per the annual India rich list released by the Forbes India, Mukesh ... first position followed by India's richest pharmaceutical magnate Dilip Shanghvi at ...
Read more: Mukesh Ambani tops Forbes' 100 Richest Indians list; Sun Pharma's Dilip Shanghvi bags no 2 spot

Pharma Reviews: Pharma companies benefits, infrastructure cos lose out due to new accounting standards: PwC ...

MUMBAI: As India Inc adapted the new accounting standards—Ind-AS— there was a jump in net income of pharma companies and increased losses ...
Read more: Pharma companies benefits, infrastructure cos lose out due to new accounting standards: PwC ...

Pharma Reviews: A Startup Dedicated to Saving Lives through Medical Collaboration

We have already started working with leading pharma companies in India who want to share their proprietary insights and gain doctors unbiased ...
Read more: A Startup Dedicated to Saving Lives through Medical Collaboration

Pharma Reviews: Patanjali's Acharya Balkrishna makes debut in Forbes' richest Indian list; RIL's Mukesh Ambani ...

Forbes India's richest person list also saw entry of Acharya Balkrishna, ... Pharmaceutical magnate Dilip Shanghvi wealth fell by $1.1 billion along with ...
Read more: Patanjali's Acharya Balkrishna makes debut in Forbes' richest Indian list; RIL's Mukesh Ambani ...

Pharma Reviews: India's Joint Secretary Of Health & Family Welfare, K.L. Sharma, To Speak At UNIQUITY India ...

22, 2016 /PRNewswire/ -- India's Joint Secretary, Ministry of Health & Family ... The Indian pharmaceutical industry — from SMEs to MNCs — will need ...
Read more: India's Joint Secretary Of Health & Family Welfare, K.L. Sharma, To Speak At UNIQUITY India ...

Pharma Reviews: UL to work closely with Pharmexcil to guide Indian pharma cos from compliance to performance

UL, an independent, global safety science major, sees Indian pharma industry with the potential to hold sway in the stringent global market.
Read more: UL to work closely with Pharmexcil to guide Indian pharma cos from compliance to performance

Pharma Reviews: Pharma industry told to exploit digital platforms to gain market access & remain competitive in the ...

The five major disruptions in Indian pharma are digital revolution, changing regulations, UCPMP, emergence of new stakeholders and growth in ...
Read more: Pharma industry told to exploit digital platforms to gain market access & remain competitive in the ...

Pharma Reviews: Pharma industry"s outlook looks healthy on increasing export, government initiatives

Indian pharmaceutical industry plays vital role in development of economy contributing towards the welfare of humanity and providing significant ...
Read more: Pharma industry"s outlook looks healthy on increasing export, government initiatives

Pharma Reviews: ACTION ON KATOCH PANEL

Indian pharmaceutical industry continues to be at the mercy of Chinese API makers and they frequently jack up prices most of the APIs forcing Indian ...
Read more: ACTION ON KATOCH PANEL

Pharma Reviews: Indian pharma cos in global alliance to fight drug resistance

The roadmap by these 13 drug firms follows the Industry Declaration signed in January 2016 at the World Economic Forum by more than 100 ...
Read more: Indian pharma cos in global alliance to fight drug resistance

Pharma Reviews: All is not well with pharma stocks with US exposure, 10 stocks lose over 20%

"Our positive view on the US generics market was based on the upside from faster approvals for Indian companies. However, increasing consolidation ...
Read more: All is not well with pharma stocks with US exposure, 10 stocks lose over 20%

Pharma Reviews: DoP to release mandatory Uniform Code of Pharmaceutical Marketing Practices soon

The mandatory code will replace the existing voluntary UCPMP. Indian pharma companies hope to see its early implementation and are upbeat on ...
Read more: DoP to release mandatory Uniform Code of Pharmaceutical Marketing Practices soon

US FDA News: FDA launches competition to spur innovative technologies to help reduce opioid overdose deaths

The U.S. Food and Drug Administration today announced the 2016 Naloxone App Competition, a public contest focused on developing innovative technologies to combat the rising epidemic of opioid overdose.
Read more: FDA launches competition to spur innovative technologies to help reduce opioid overdose deaths

US FDA News: FDA grants accelerated approval to first drug for Duchenne muscular dystrophy

The U.S. Food and Drug Administration today approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Exondys 51 is specifically indicated for patients who have a confirmed mutation of the dystrophin gene amenable to exon 51 skipping, which affects about 13 percent of the population with DMD.
Read more: FDA grants accelerated approval to first drug for Duchenne muscular dystrophy

Pharma Reviews: CIPI urges DoP to direct expert panel to come out with clarity on pricing policy of patented drugs soon

With an aim to ensure enhanced access to affordable medicines in the country, the Confederation of Indian Pharmaceutical Industry (CIPI) has urged ...
Read more: CIPI urges DoP to direct expert panel to come out with clarity on pricing policy of patented drugs soon

Pharma Reviews: Teva Pharmaceutical inks largest realty deal for HQ at Goregaon

The Israeli multinational pharmaceutical company will be shifting its India headquarters and consolidating six offices in Mumbai in this newly leased ...
Read more: Teva Pharmaceutical inks largest realty deal for HQ at Goregaon

Pharma Reviews: Tamil Nadu losing half of pharma units to northeast states

CHENNAI: From being a forerunner in promotion of pharmaceutical ... said J Jayaseelan, State chairman of the Indian Drug Manufacturers Association ...
Read more: Tamil Nadu losing half of pharma units to northeast states

Pharma Reviews: Lupin says looking at buyout opportunities in domestic market

“For several years now, large Indian pharma companies have been looking to acquire select portfolio of domestic or foreign companies to spur their ...
Read more: Lupin says looking at buyout opportunities in domestic market

US FDA News: FDA permits marketing of balloon device to treat persistent Eustachian tube dysfunction

The U.S. Food and Drug Administration today permitted marketing of a device that uses a small balloon to treat persistent Eustachian tube dysfunction (ETD), a condition in which pressure, pain or clogged or muffled sensations occur in the ear.
Read more: FDA permits marketing of balloon device to treat persistent Eustachian tube dysfunction

US FDA News: Hyoscyamine sulfate 0.125mg by Virtus Pharmaceuticals: Recall - Superpotent and Subpotent Test Results

Adverse event reports involving hallucinations, stroke-like symptoms, confusion, dizziness, blurred vision, dry mouth, slurred speech, imbalance, and disorientation.
Read more: Hyoscyamine sulfate 0.125mg by Virtus Pharmaceuticals: Recall - Superpotent and Subpotent Test Results

US FDA News: FDA protects kids from illegal sales of e-cigarettes, e-liquids and cigars

The U.S. Food and Drug Administration announced today it has taken action against 55 tobacco retailers by issuing the first warning letters for selling newly regulated tobacco products, such as e-cigarettes, e-liquids and cigars, to minors. These actions come about a month after the FDA began enforcing new federal regulations making it illegal nationwide to sell e-cigarettes, cigars, hookah tobacco, and other newly regulated tobacco products to anyone under age 18 in person and online, and requiring retailers to check photo ID of anyone under age 27, among other restrictions.
Read more: FDA protects kids from illegal sales of e-cigarettes, e-liquids and cigars

Pharma Reviews: Sun Pharma, Reliance top companies by legal expenses as costs rise

India Inc.'s legal and professional expenses continued to increase in the year through March 2016 as companies spent more on complying with new ...
Read more: Sun Pharma, Reliance top companies by legal expenses as costs rise

Pharma Reviews: GST may help pharma industry regain lost share

“The share of Gujarat in India's pharmaceutical production was 42% a decade ago. Tax havens attracted many units from Gujarat bringing down ...
Read more: GST may help pharma industry regain lost share

Pharma Reviews: FDA norms punch a Rs 5 crore hole in Pharma Industry

ET INTELLIGENCE GROUP: For Indian pharmaceutical companies, compliance with US Food and Drug Administration norms has emerged as the ...
Read more: FDA norms punch a Rs 5 crore hole in Pharma Industry

Pharma Reviews: Pharma units in Gujarat look with high hopes on GST roll out

We expect more than 50 units to return to Gujarat, this will improve our share in the India's pharma sector," said Nirav Mehta, vice-chairman, Gujarat ...
Read more: Pharma units in Gujarat look with high hopes on GST roll out

Pharma Reviews: Marken Expands Its Presence In India

The Indian pharma industry is expected to grow over 15 percent per year between 2015 and 2020 and outperform the global pharma industry ...
Read more: Marken Expands Its Presence In India

Pharma Reviews: Indian pharma market registers strong growth of 15.3% in August 2016

The Indian pharmaceutical market (IPM) has registered a strong growth of 15.3 per cent to Rs. 9,643 crore during August 2016 as against 13.2 per ...
Read more: Indian pharma market registers strong growth of 15.3% in August 2016

Pharma Reviews: SURVEY OF SPURIOUS DRUGS

It covers 224 molecules of 15 major therapeutic drug groups relevant to Indian market. Indian Statistical Institute jointly with National Sample Survey ...
Read more: SURVEY OF SPURIOUS DRUGS

Pharma Reviews: GST may help pharma industry regain lost share

"The share of Gujarat in India's pharmaceutical production was 42% a decade ago. Tax havens attracted many units from Gujarat bringing down ...
Read more: GST may help pharma industry regain lost share

US FDA News: FDA approves VisuMax Femtosecond Laser to surgically treat nearsightedness

The U.S. Food and Drug Administration today approved the VisuMax Femtosecond Laser for the small incision lenticule extraction (SMILE) procedure to reduce or eliminate nearsightedness in certain patients 22 years of age or older.
Read more: FDA approves VisuMax Femtosecond Laser to surgically treat nearsightedness

Pharma Reviews: Regulators step up scrutiny of drug makers

Four of Ranbaxy's plants in India--now owned by Sun Pharmaceutical ... Quality excellence is the new frontier for the Indian pharmaceutical industry," ...
Read more: Regulators step up scrutiny of drug makers

Pharma Reviews: Regulators step up scrutiny of drug makers

Four of Ranbaxy's plants in India--now owned by Sun Pharmaceutical ... Quality excellence is the new frontier for the Indian pharmaceutical industry," ...
Read more: Regulators step up scrutiny of drug makers

Pharma Reviews: Taro Pharmaceutical Industries under anti-trust scanner for price hike

MUMBAI: The uproar over high drug prices in the US has come to hit Indian drug companies as Sun Pharmaceutical Industries unit Taro ...
Read more: Taro Pharmaceutical Industries under anti-trust scanner for price hike

Pharma Reviews: The new IPR policy: An amateur attempt to regulate the pharmacy of the world

Amidst the clamour about India's inefficient Intellectual Property Rights (IPR) regime, the NDA ... How does it affect the Indian Pharmaceutical Industry?
Read more: The new IPR policy: An amateur attempt to regulate the pharmacy of the world

Pharma Reviews: Buy Sun Pharma, IOC, Jain Irrigation Systems: Rahul Shah

Buy Sun Pharma, IOC, Jain Irrigation Systems: Rahul Shah. Rahul Shah of Motilal Oswal is of the view that one can buy Sun Pharma, Indian Oil ...
Read more: Buy Sun Pharma, IOC, Jain Irrigation Systems: Rahul Shah

Pharma Reviews: Pharma companies Code should be seen to be fair

For the doctors and the pharma companies to follow the code, it is important that it ... The department of pharmaceuticals requires companies to have a ... of a pharmaceutical company, said, “We have found that most Indian patients ...
Read more: Pharma companies Code should be seen to be fair

Pharma Reviews: PI Industries plans foray into pharma sector

PI Industries plans foray into pharma sector ... on two to three high-potential molecules for the Indian market under the in-licensing arrangement.
Read more: PI Industries plans foray into pharma sector

Pharma Jobs: Regional Manager- Sales & Marketing

Company: Universal Starch-Chem Allied Ltd
Qualification: Any graduate, B.Pharm, B.Sc, MBA, M.Pharm, M.Sc
Experience: 3 to 10
location: Ahmedabad, Mumbai
Ref: 19320979
Summary: Looking for focused and target oriented marketing individuals with a zeal for growth.

Read more: Regional Manager- Sales & Marketing

US FDA News: GlucaGen HypoKit (glucagon [rDNA origin] for injection) by Novo Nordisk Inc: Recall - Detached Needles on Syringe

Affected product with detached needle cannot be used as prescribed. Untreated hypoglycemia can eventually lead to unconsciousness and seizures, which can prove fatal.
Read more: GlucaGen HypoKit (glucagon [rDNA origin] for injection) by Novo Nordisk Inc: Recall - Detached Needles on Syringe

US FDA News: FDA provides $21.8 million to states for FSMA produce safety rule implementation

The U.S. Food and Drug Administration today announced the awarding of a total of $21.8 million to support 42 states to help implement the FDA Food Safety Modernization Act (FSMA) produce safety rule. The rule, which the FDA finalized in November 2015, establishes science-based minimum standards for the safe growing, harvesting, packing and holding of fruits and vegetables grown for human consumption.
Read more: FDA provides $21.8 million to states for FSMA produce safety rule implementation

Pharma Reviews: KWE India sets up dedicated pharmaceutical warehouse

KWE India, the Indian subsidiary of Kintetsu World Express and a part of the Japanese global conglomerate Kintetsu Group, has unveiled India's first ...
Read more: KWE India sets up dedicated pharmaceutical warehouse

US FDA News: Family Care Eye Wash by United Exchange Corp: Recall - Microbial Contamination

Use of a contaminated product could be calamitous for any population since there is a reasonable probability of a potentially sight-threatening eye infection.
Read more: Family Care Eye Wash by United Exchange Corp: Recall - Microbial Contamination

Pharma Reviews: Pharma companies air concerns over plans to cap prices

NEW DELHI: Indian pharma industry heavyweights have raised serious concerns over plans by the government to amend the country's drug pricing ...
Read more: Pharma companies air concerns over plans to cap prices

Pharma Reviews: need2know: Five macro triggers that market may watch today

Indian pharma industry heavyweights have raised serious concerns over plans by the government to amend the country's drug pricing norms to allow ...
Read more: need2know: Five macro triggers that market may watch today

US FDA News: Eye Wash/Eye Irrigating Solutions Distributed by Major Pharmaceuticals and Rugby Laboratories: Recall - Microbial Contamination

Use of a contaminated product could be calamitous for any population since there is a reasonable probability of a potentially sight-threatening eye infection.
Read more: Eye Wash/Eye Irrigating Solutions Distributed by Major Pharmaceuticals and Rugby Laboratories: Recall - Microbial Contamination

US FDA News: Ovarian Cancer Screening Tests: Safety Communication - FDA Recommends Against Use

Using unproven ovarian cancer screening tests may be harmful for women with increased risk for developing ovarian cancer.
Read more: Ovarian Cancer Screening Tests: Safety Communication - FDA Recommends Against Use

Pharma Reviews: Sun Pharma signs distribution agreement with Mitsubishi Tanabe

Chennai, Sep 6 (IANS) Indian drug major Sun Pharmaceutical Industries Ltd on Tuesday said it has signed a strategic distribution agreement with ...
Read more: Sun Pharma signs distribution agreement with Mitsubishi Tanabe

Pharma Reviews: Certificate by LSSSDC must for drug manufacturing firms'

With the Indian pharma industry facing huge shortage of skilled human resources, the regulator, Drug Controller-General of India (DCGI) has made it ...
Read more: Certificate by LSSSDC must for drug manufacturing firms'

Pharma Reviews: Systech forays into India, opens office in Mumbai

The focus of Uniquity India will be on global serialization regulations affecting the pharmaceutical industry and how effective technologies will be ...
Read more: Systech forays into India, opens office in Mumbai

Pharma Reviews: Sun Pharma partners Mitsubishi Tanabe to sell 14 prescription brands in Japan

Till date, Lupin Ltd is the only Indian pharmaceuticals company to have a presence in the Japanese generics market, which currently accounts for 12% ...
Read more: Sun Pharma partners Mitsubishi Tanabe to sell 14 prescription brands in Japan

Pharma Reviews: Pharmasafe India to be held in Mumbai from September 22 to 23

Extending this initiative to the Indian pharma sector, Pharmasafe India conference aims to be the collective voice of the industry to tackle sub-standard ...
Read more: Pharmasafe India to be held in Mumbai from September 22 to 23

Pharma Reviews: Systech Continues Global Expansion With Move Into India

Pharmaceutical manufacturers in India supply a high volume of superior ... Systech's product suite is extremely attractive to the Indian SME sector ...
Read more: Systech Continues Global Expansion With Move Into India

Pharma Reviews: GST impact: Here's why pharma companies must remodel their supply chain structure

GST is a tax triggered business transformation which is expected to be a game changing reform for the Indian economy. It will develop a common ...
Read more: GST impact: Here's why pharma companies must remodel their supply chain structure

Pharma Reviews: Panel to investigate pharma firms red-listed by Vietnam

“The ministry of commerce has initiated discussions with us about looking into the manufacturing practices of Indian pharmaceutical companies ...
Read more: Panel to investigate pharma firms red-listed by Vietnam

Pharma Reviews: TPP to have serious implications for pharma industry: Study

According to the report 'Indian Pharmaceutical Industry: Challenges and Prospects', even as the domestic pharmaceutical industry has acquired a ...
Read more: TPP to have serious implications for pharma industry: Study

Pharma Jobs: Quality control, Quality Assurance, Research & Development

Company: SHR Consultant
Qualification: M.Sc
Experience: 2 to 7
location: Hyderabad / Secunderabad
Ref: 19280787
Summary: Looking for Quality control, Quality Assurance, Research & Development ,QA & QC chemist – Location Hyderabad & Vijayawada (Exp 2 to 8yrs ) R&D – Hyderabad ( EXP 2 to 8 yrs) AR&D – Hyderabad (....
Read more: Quality control, Quality Assurance, Research & Development

US FDA News: FDA allows marketing of clot retrieval devices to reduce disability in stroke patients

The U.S. Food and Drug Administration today allowed marketing of two Trevo clot retrieval devices as an initial therapy for strokes due to blood clots (ischemic) to reduce paralysis, speech difficulties and other stroke disabilities. These devices should be used within six hours of symptom onset and only following treatment with a clot-dissolving drug (tissue plasminogen activator or t-PA), which needs to be given within three hours of symptom onset.
Read more: FDA allows marketing of clot retrieval devices to reduce disability in stroke patients

US FDA News: FDA issues final rule on safety and effectiveness of antibacterial soaps

The U.S. Food and Drug Administration today issued a final rule establishing that over-the-counter (OTC) consumer antiseptic wash products containing certain active ingredients can no longer be marketed.
Read more: FDA issues final rule on safety and effectiveness of antibacterial soaps

Pharma Reviews: Gujarat pharma industry keen to implement GST to escape skewed tax regime

Today Gujarat contributes to 33 per cent of India's pharma sector turnover. However, Viranchi Shah, vice chairman of the Indian Drugs Manufacturer's ...
Read more: Gujarat pharma industry keen to implement GST to escape skewed tax regime

US FDA News: Mass Spectrometers by Sciex: Safety Communication - Incorrect Assignment of Test Results

Health care professionals may make inaccurate clinical diagnoses or inaccurate medical treatment decisions for patients by relying on incorrect results from the devices, which may lead to serious adverse health consequences.
Read more: Mass Spectrometers by Sciex: Safety Communication - Incorrect Assignment of Test Results

Pharma Reviews: Indian pharma segment may get impacted by TPP and TTIP agreements: Exim Bank

An Exim Bank study “Indian Pharmaceutical Industry: Challenges and Prospects” has noted that although the Indian pharmaceutical industry acquired ...
Read more: Indian pharma segment may get impacted by TPP and TTIP agreements: Exim Bank

Pharma Reviews: Condot Systems and its Matthews Swedot partnership flourishes

Condot has around 12,000 installations in India. ... Mathew also has a company in China, specialising in marking systems. ... From a pharma perspective, leading Indian global players like Sun Pharma, Cipla, Lupin, etc, already have ...
Read more: Condot Systems and its Matthews Swedot partnership flourishes

Pharma Reviews: India pharma loan may be just the cure for M&A lull

Two Indian companies are vying for the UK and Ireland assets of Israeli firm Teva Pharmaceutical Industries and have lined up loan packages to back ...
Read more: India pharma loan may be just the cure for M&A lull

Pharma Reviews: Lupin receives tentative approval for generic version of Pfizer's Zithromax

Govt plans to make India pharma R&D hub in 4 years The government is ... The plant will produce the active pharmaceutical ingredients (API) for ...
Read more: Lupin receives tentative approval for generic version of Pfizer's Zithromax

US FDA News: Vascu-Guard Peripheral Vascular Patch by Baxter International: Letter to Health Care Providers - Potential Risk of Severe Bleeding and Hematomas

Reports of intraoperative or postoperative bleeding and hematomas, some of which required additional intervention, and three patient deaths potentially related to this issue that occurred shortly after carotid endarterectomy surgery.
Read more: Vascu-Guard Peripheral Vascular Patch by Baxter International: Letter to Health Care Providers - Potential Risk of Severe Bleeding and Hematomas

Pharma Reviews: Growth trajectory for Indian pharmaceutical industry to remain moderate: ICRA

ICRA expects growth trajectory for Indian pharmaceutical industry to moderate on back of slowing growth from US given the relatively moderate ...
Read more: Growth trajectory for Indian pharmaceutical industry to remain moderate: ICRA